Total submissions: 18
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000759042 | SCV000167691 | benign | not provided | 2018-11-30 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 24728327, 27595995, 21244692, 26976419, 30851065) |
Ambry Genetics | RCV000132487 | SCV000187581 | benign | Hereditary cancer-predisposing syndrome | 2014-11-24 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000203747 | SCV000262385 | benign | Familial cancer of breast | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000203747 | SCV000488435 | benign | Familial cancer of breast | 2016-03-28 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000132487 | SCV000684582 | benign | Hereditary cancer-predisposing syndrome | 2014-11-22 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000120559 | SCV000806867 | benign | not specified | 2017-07-31 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000120559 | SCV000860561 | benign | not specified | 2018-04-06 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000759042 | SCV000888103 | benign | not provided | 2022-09-01 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000759042 | SCV000892300 | benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | CHEK2: BP4, BS1, BS2 |
Genetic Services Laboratory, |
RCV000120559 | SCV002070843 | benign | not specified | 2021-05-03 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000132487 | SCV002537050 | benign | Hereditary cancer-predisposing syndrome | 2020-04-28 | criteria provided, single submitter | curation | |
CHEO Genetics Diagnostic Laboratory, |
RCV003149830 | SCV003838120 | benign | Breast and/or ovarian cancer | 2022-05-25 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV000203747 | SCV004017049 | benign | Familial cancer of breast | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV000203747 | SCV004020180 | likely benign | Familial cancer of breast | 2023-03-09 | criteria provided, single submitter | clinical testing | This variant is considered likely benign. This variant is strongly associated with less severe personal and family histories of cancer, typical for individuals without pathogenic variants in this gene [PMID: 25085752]. |
Center for Genomic Medicine, |
RCV000120559 | SCV004024689 | benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000759042 | SCV005210263 | likely benign | not provided | criteria provided, single submitter | not provided | ||
ITMI | RCV000120559 | SCV000084713 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
True Health Diagnostics | RCV000132487 | SCV000788001 | likely benign | Hereditary cancer-predisposing syndrome | 2018-01-12 | no assertion criteria provided | clinical testing |